Keyword Index

A

ab initio MO method　15

aberrant crypt foci (ACFs)　6, 9

actinin-4　5

2-amino-1-methyl-6-phenylimidazo 

　[4,5-b]pyridine (PhIP)　6, 9, 30

aminophenylnorharman　24

AML1　18

AML1-MTG8　18

AML1-MTG8-binding protein (MTGR1) 19

angiogenesis　27

anti-angiogenic-activity　9

anti-mitotic agent　13

anti-tumor immunity　12

antisense　32

antisense K-RAS RNA expression 

　adenovirus vector　27

anxiety in cancer patients　43

AP-PCR fingerprints　28

apoptosis　14, 16, 25

arbitrarily primed (AP)-PCR　28

Asialo GM1+ and CD8+ cells　9

atelocollagen　32

atypical adenomatous hyperplasia 


　(AAH)　36, 40
　
B
b-catenin　25

b-cell damage　7

bFGF　36

Big Blue mice　31

biostatistics　38

BRCA1 gene　28

　
C
c-erbB-2　5, 26

C3b chain　9

cabbage butterfly　25

caffeine　9

calcium-binding protein　16

cancer databases　20

cancer information　20

cancer susceptibility　11, 30

carcinogenicity　6

case-control study　39

caspase　14

cell sociology　22

cell tropism　22

cell-to-cell interactions　22

chemopreventive agent　25

chemopreventive effects　8

chromosome alterations　5

cisplatin resistance　13

clinical image　20

clinical trials　21

clinicopathological studies　5

Colon carcinoma 26 (Colon 26)　9

colony-forming capacity (CFC)　23

combination therapy　13

congenic rat strains　6

coping (to cancer)　42

CpG island(s)　10, 31

CYP1A2　9

cytochrome P450　37

cytotoxic T cell epitope　22

D

dehydroepiandrosterone (DHEA)　8

depression in cancer patients　42

diagnosis of various tumors　5

dietary modification　39

DNA hypermethylation　4

DNA methylation　31

DNA repair　10

DNA topoisomerases　13

drug resistance　13

E

E-cadherin-mediated cell adhesion system　4

early hepatocellular carcinoma　4

ectopic hormone/cytokine syndromes　16

embryonic stem cell (ES cell)　32

environmental and genetic interaction　39

epidemiology and statistics　20, 38

epigenetic alterations　31

esophageal cancer　26

ethyl 3-(4-geranyloxy-3-methoxyphenyl)

　-2-propionate (EGMP)　8

expression cloning　23

extracellular matrix glycoprotein　23

　
F
familial cancer　11, 16, 20

fatigue in cancer patients　42

FGFR　36

fibrotic focus　36

fighting spirit　42

fluorescence in situ hybridization　5

fluorescence-based SSCP (F-SSCP) 

　analysis　28

food frequency questionnaire　38

foods and nutrients　38

Frizzled gene　27

FUS/TLS　18

　
G
G4'-structure　7

ganglioside GM3 synthase　23

gap junction　9

gastric cancer　26

gastric cancer-prone families　11

gastritis with H. pylori infection 34

gene amplification　26

gene therapy　33, 41

gene disruption　7

genetic polymorphism　11

genetic susceptibility　6

genetic testing　16

genomic instability　6

genomic subtraction method　26

germ cell tumor　32

glycosphingolipids　23

GRB7　26

　
H
H. pylori　34

H2O2　15

HB-EGF　14

HCV genome　22

heterocyclic amine (HCA)　6, 30

homozygous deletion　10

hot tea drinking　20

HST-1(FGF-4)　32

human c-Ha-ras proto-oncogene　8

human OGG1 (oxoguanine DNA glycosylase) gene　11

human U1 snRNA　41

8-hydroxyguanine　11

hypercalcemia　16

hypermethylated CpG islands　29

hyperplastic foci　4

　
I
inducible nitric oxide synthase (iNOS)　25

insulin as a tumor promoter　9

interleukin 2 (IL-2)　34

interleukin-6 (IL-6)　16

intermediate T-cell receptor (TCRint) cells　12

internet　21

intestinal carcinogenesis　8

　
J
Japan Clinical Oncology Group (JCOG)　21

Japan Public Health Center-based 

　Prospective Study　20
　

K
K-SAM/FGFR2 gene　4, 26

knockout rats　32

Kr殫pel-like zinc finger protein　27

　
L
lacI transgenic　31

lactoferrin (bLF)　8, 22

leukemia inhibitory factor (LIF)　32

limited resection　37

linkage mapping　6

long-term BM culture (LTBMC)　23

loss of heterozygosity (LOH)　28

lung adenocarcinoma　36

lung cancer (treatment)　40

lung metastasis　9

　
M
magnetic fields　16

medullary thyroid carcinoma　17

MEN1　16

MEN2　16

metaplastic glands　37

metastasis suppressor gene　11

methyl-CpG binding domain (MBD) 

　column chromatography　29

methylated DNA fragment　29

minisatellite　7

mitochondria　15

MN-binding proteins　7

molecular therapeutics　16

mouse liver tumors　31

mRNA splicing　41

ms-myc　14

MS-RDA　31

MTG16　18

multiple endocrine neoplasia (MEN) 16

　
N
N-methyl-N'-nitro-N-nitrosoguanidine 

　(MNNG)　30

natural killer (NK)-like T (NKT)

　cells 12

negative-strand HCV RNA　22

NGFI-B　16

nimesulide　24

NK cell-like cytotoxic activity　34

NK1.1+T cell　34

NK1.1-IL-2Rb+T cells　34

NOR-1　16

norharman　24

nucleus-fibrotic focus-fat invasion

　(NFF) classification　36

nutrients and cancer　38

　
P
p300　18

p53　10

PAC clone　29

pancreatic cancer　16,27

PBTA-1　24

PCR-based analysis of radiation

　hybrid panels　28

PCR-SSCP analysis　28

PhIP(2-amino-1-methy1-6-phenylimidazo 

　[4.5-b]pyridine)　6,9,30

pierisin　25

pleural metastasis　11

poly (ADP-ribose) polymerase　7

polymorphism　39

PPARg　41

precancerous lesion　36

prognostic analysis　39

prognostic factors　37

programmed cell death　14

prospective study　38

prostaglandin J2　41

protein phosphatases　31

psycho-oncology　42

paychosocial interventions　43

Q

quality of life (QOL)　43

R

radon exposure　20

randomized controlled trial　39

rat genetic markers　30

PBP56/hTAFII68　18

representational difference analysis (RDA)　30

RET　17

S

second primary tumors　20

segregation of partly melted molecules

　(SPM) method　29

selective COX-2 inhibitor　24

sialylmotifs　23

sialyltransferase　23

SOS-signaling mediator　41

spore dosimetry　19

stem gland　40

syncytiotrophoblastic giant cell (STGC)　7

stomach cancer and chronic  gastritis　30,39

streak type of colon cancer　5

Streptococcus anginosus　26

suppression of the cellular tumorigenicity　29

3q21q26 syndrome　10

　
T
t (16;21) (q24;q22) translocation　18

Taq DNA polymerase　14

tenascin-C (TN-C)　23

tetrahydrocurcumin (THC)　8

thioredoxin (TRX)　13.34

3q21q26 syndrome　10

transgenic rats　8

　

triazine derivatives　9

TSC genes　40

tumor metastasis (and T cells)　13

tumor suppressor gene　10,28

tumor-regressing factor　9

type II transmembrane topology　23

tyrosine phosphorylation　4

U

U5A2-13 monoclonal antibody　12

UKLF　27

V

validity of questionnaire　38

VEGF　41

viral carcinogenesis　22

vitamin C　38

W

WHO Collaborating Centre　21

Wnt receptor　27

X

X chromosome inactivation　40

Y

YAC clone　29